Mental health ecosystem

We are helping build a mental health ecosystem that supports care models of the future and promotes access and health equity over the long term.

We need a clinical and cultural shift in mental health care. Novel therapies, backed by rigorous evidence, are a first step. But new, effective care pathways that make these therapies accessible to all who can benefit can only emerge from a collaboration of mental health companies, health systems, and payers. We are joining forces with health innovators to create this ecosystem. Three areas are of particular importance to us in doing so:

Affordability and reimbursement strategy – Our aspiration is to ensure that COMP360 psilocybin treatment, if approved, is made accessible to as many patients who might benefit as possible.
Equitable access – We work with experts to better understand the experience socially disadvantaged populations have of mental health care and aim to ensure broad access to COMP360 if regulatory approval is obtained.
Health systems strengthening – We work with health systems providers and innovators to accelerate research for mental health, through our own and independent research programmes, and to prepare the effective delivery of COMP360 psilocybin treatment at scale.

Our actions

300 +

people surveyed to understand the needs of marginalised groups

Our actions

partnerships with health systems to conduct research and train therapists

$ 300 ,000

donated to 3 independent mental health researchers through OneMind

Our actions

Footnotes

^{1 Michaels, T.I., Purdon, J., Collins, A. et al. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry 18, 245 (2018). https://doi.org/10.1186/s12888-018-1824-6}

^{Data points – Refer to data as of December 31, 2022.}

We strive to be a responsible organisation, through the working environment we create for our employees, the way we engage with our stakeholders, and our business practices.

Discover more

Mental health ecosystem

We are helping build a mental health ecosystem that supports care models of the future and promotes access and health equity over the long term.

We engage with stakeholders to understand what is necessary to bring our therapies to real-world settings and attain reimbursement.

We generate evidence to demonstrate the effectiveness of our therapies to healthcare payers.

We created a Patient Access and Health Systems Advisory Board.

Our aspiration is to bring our therapies to anyone who may be helped by them, regardless of race, ethnicity, or socioeconomic status.

We train our therapists to provide culturally sensitive care and we support a diverse community of therapists.

We engage with policymakers to advocate for broad patient access.

We have formed long-term strategic partnerships with two health systems in the US and in the UK to conduct clinical and real-world research and train therapists.

We are a key contributor to the UK Government’s Mental Health Mission to accelerate research and improve patient outcomes in mental health.

We participate in the Psychiatry Consortium to support research that accelerates drug discovery.

We provide funding for independent researchers and investigators to advance knowledge of and treatment for mental health conditions.

We strive to be a responsible organisation, through the working environment we create for our employees, the way we engage with our stakeholders, and our business practices.